CIK 0001811063 · Non-accelerated filer<br>Smaller reporting company
Nuvation Bio Inc.
Sign in to watch- Ticker
- NUVB
- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 850862255
- Phone
- 332-208-6102
- Business address
- 1 PENNSYLVANIA PLAZA, SUITE 3805, NEW YORK, NY, 10019
- Former names
- Panacea Acquisition Corp
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $709,240
- in 1 filing, $709K under 10b5-1 plans
Net −$709,240. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-05-16 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +118,784 | 118,784 | ||
| 2022-05-16 | FALBERG KATHRYN E Director | Grant or award · Stock Option (Right to Buy) | +118,784 | 118,784 | ||
| 2022-05-16 | VERNON W ANTHONY Director | Grant or award · Stock Option (Right to Buy) | +118,784 | 118,784 | ||
| 2022-05-16 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +118,784 | 118,784 | ||
| 2022-04-05 | Omega Fund V, L.P. 10% owner | Sale | −2,500,000 | $5.60 | $14.0M | 20,457,340 |
| 2022-02-28 | Hattersley Gary Chief Scientific Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-02-28 | Hanley David C. Chief Technical Operations | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-02-28 | Markel Stacy Chief People Officer | Grant or award · Stock Option (Right to Buy) | +500,000 | 500,000 | ||
| 2022-02-28 | Fox Jennifer A. Chief Financial Officer | Grant or award · Stock Option (Right to Buy) | +600,000 | 600,000 | ||
| 2022-02-28 | Hung David President and CEO | Grant or award · Stock Option (Right to Buy) | +2,000,000 | 2,000,000 | ||
| 2021-12-15 | Omega Fund V, L.P. 10% owner | Sale | −500,000 | $10.07 | $5.0M | 22,957,340 |
| 2021-12-07 | Omega Fund V, L.P. 10% owner | Sale | −1,400,000 | $9.80 | $13.7M | 23,457,340 |
| 2021-11-24 | NODELMAN OLEG Director | Purchase | +163,268 | $7.69 | $1.3M | 7,361,675 |
| 2021-11-24 | NODELMAN OLEG Director | Purchase | +21,758 | $7.69 | $167K | 1,169,241 |
| 2021-11-23 | Omega Fund V, L.P. 10% owner | Sale | −36 | $9.75 | $351 | 24,857,376 |
| 2021-11-22 | Omega Fund V, L.P. 10% owner | Sale | −295,000 | $9.76 | $2.9M | 24,857,376 |
| 2021-11-03 | Omega Fund V, L.P. 10% owner | Sale | −2,000,000 | $9.25 | $18.5M | 25,152,376 |
| 2021-10-29 | NODELMAN OLEG Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 | ||
| 2021-10-29 | BLICKENSTAFF KIM D Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 | ||
| 2021-10-29 | WELCH DANIEL G Director | Grant or award · Stock Option (Right to Buy) | +45,229 | 45,229 |
Page 11 of 15 · 291 trades